請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41475完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 劉興華(Shing-Hwa Liu) | |
| dc.contributor.author | Tung-Ying Lu | en |
| dc.contributor.author | 呂東穎 | zh_TW |
| dc.date.accessioned | 2021-06-15T00:20:15Z | - |
| dc.date.available | 2011-02-17 | |
| dc.date.copyright | 2009-02-17 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-02-10 | |
| dc.identifier.citation | Abe Y, Aida Y, Abe T, Hirofuji T, Anan H, Maeda K (2000) Development of mineralized nodules in fetal rat mandibular osteogenic precursor cells: requirement for dexamethasone but not for beta-glycerophosphate. Calcif Tissue Int 66:66-9.
Agarwal S, Roy S, Ray A, Mazumder S, Bhattacharya S (2008) Arsenic trioxide and lead acetate induce apoptosis in adult rat hepatic stem cells. Cell Biol Toxicol. Epub ahead of print]. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H (2004) PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-55. Amri EZ, Dani C, Doglio A, Etienne J, Grimaldi P, Ailhaud G (1986) Adipose cell differentiation: evidence for a two-step process in the polyamine-dependent Ob1754 clonal line. Biochem J 238:115-22. Aposhian H（1989）Biochemical toxicology of arsenic. Rev Biochem Toxicol 10: 265-299. Banovac K, Koren E (2000) Triiodothyronine stimulates the release of membrane-bound alkaline phosphatase in osteoblastic cells. Calcif Tissue Int 67:460-5. Bellows CG, Heersche JN, Aubin JE (1992) Inorganic phosphate added exogenously or released from beta-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone Miner 17:15-29. Bertolero F, Pozzi G, Sabbioni E, Saffiotti U (1987) Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 8:803-8. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-42. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z (1996) In virto studies on cellular and molecular mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88:1052-1061. Carlson-Lynch H, Beck BD, Boardman PD (1994) Arsenic risk assessment.Environ. Health Perspect 102:354-356. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH (2007) Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling. Endocrinology 148:4267-75. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-86. Cui X, Kobayashi Y, Akashi M, Okayasu R (2008) Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer. Curr Med Chem 15:2293-304. Dean DD, Schwartz Z, Bonewald L, Muniz OE, Morales S, Gomez R, Brooks BP, Qiao M, Howell DS, Boyan BD (1994) Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of beta-glycerophosphate and ascorbic acid. Calcif Tissue Int 54:399-408. Ducy P (2000) Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219:461-71. Fan SR, Ho IC, Yeoh FL, Lin CJ, Lee TC (1996) Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells. Muta Res 368: 165-169. Fajas L (2003) Adipogenesis: a cross-talk between cell proliferation and cell differentiation. Ann Med 35 :79-85. Gurley LR, Walters RA, Jett JH, Tobey RA (1980) Response of CHO cell proliferation and histone phosphorylation to sodium arsenite. J.Toxicol. Environ. Health 6: 87-105. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG (2002) Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277:33361-8. Herzog EL, Chai L, Krause DS (2003) Plasticity of marrow-derived stem cells. Blood 102 :3483-93. Harrison G, Shapiro IM, Golub EE (1995) The phosphatidylinositol-glycolipid anchor on alkaline phosphatase facilitates mineralization initiation in vitro. J Bone Miner Res 10:568-73. Hikiji H, Shin WS, Koizumi T, Takato T, Susami T, Koizumi Y, Okai-Matsuo Y, and Toyo-Oka T (2000) Peroxynitrite production by TNF-alpha and IL-1beta: implication for suppression of osteoblastic differentiation. Am J Physiol Endocrinol Metab 278: E1031-1037. Ishinishi N, Yamamoto A, Hisanaga A, Inamasu T (1983) Tumorigenicity of arsenic trioxide to the lung in syrian golden hamsters by intermittent instillations. Cancer Lett 21: 141-147. Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC (1996) Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 97:1732-40. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T (2008) Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression. Am J Physiol Endocrinol Metab 296 :E139-46. Kadiyala S, Young RG, Thiede MA, Bruder SP (1997) Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6:125-34. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89(5):755-64. Koli K, Ryynänen MJ, Keski-Oja J (2008) Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells. Bone 43:679-88. Kono SJ, Oshima Y, Hoshi K, Bonewald LF, Oda H, Nakamura K, Kawaguchi H, Tanaka S. (2007) Erk pathways negatively regulate matrix mineralization. Bone 40:68-74. Epub 2006 Sep 15 Lacey JD, Hodge JC (1998) Pisiform and hamulus fractures: easily missed wrist fractures diagnosed on a reverse oblique radiograph. J Emerg Med 16 :445-52. Lee TH, Yu SL, Kim SU, Kim YM, Choi I, Kang SW, Rhee SG, Yu DY (1999) Characterization of mouse peroxiredoxin I genomic DNA and its expression. Gene 239: 243-250. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270:12953-6. Li B, Ishii T, Tan CP, Soh JW, Goff SP. (2002) Pathway of induction of peroxiredoxin I expression in osteoblasts: : roles of p38 mitogen-activated protein kinase and protein kinase C. J. Biol. Chem 277:12418-12422. Lin TH, Yang RS, Tang CH, Lin CP, Fu WM (2007) PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone 41:562-74. Mann S, Droz PO, Vahter M (1996) A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Toxicol Appl Pharmacol 137:8-22. Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang LC, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Böhnlein E, Storb R, Sandmaier BM (2000) Mesenchymal stem cells as vehicles for gene delivery. Clin Ortho (379 Suppl):S71-90. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B (2004) Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3: 379-389. Nagai A, Kim WK, Lee HJ, Jeong HS, Kim KS, Hong SH, Park IH, Kim SU (2007) Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS ONE 2 :e1272. Novakofski J (2004) Adipogenesis: usefulness of in vitro and in vivo experimental models. J Anim Sci 82:905-15. Nuttall ME, Gimble JM (2004) Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 4 :290-4. Pei L, Tontonoz P (2004) Fat's loss is bone's gain. J Clin Invest 113 :805-6. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop DJ (1995) Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 92 :4857-61. Prusty D, Park BH, Davis KE, Farmer SR (2002) Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226-32. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-7. Raisz LG (2001) Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med 110 Suppl 3A:43S-5S. Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernández-Luna JL, González-Macías J (1995) Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res 10:439-46. Roboz GJ, Ritchie EK, Curcio T, Provenzano J, Carlin R, Samuel M, Wittenberg B, Mazumdar M, Christos PJ, Mathew S, Allen-Bard S, Feldman EJ (2008) Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia. Cancer 113:2504-11. Rodrı́guez J, Berzas JJ, Castañeda G, Rodrı́guez N (2004) Determination of sildenafil citrate (viagra) and its metabolite (UK-103,320) by square-wave and adsorptive stripping square-wave voltammetry. Total determination in biological samples. Talanta 62:427-432. Rosen ED, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14:1293-307. Rosen ED, Spiegelman BM (2001) PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276 :37731-4. Roy ME, Nishimoto SK, Rho JY, Bhattacharya SK, Lin JS, Pharr GM (2001) Correlations between osteocalcin content, degree of mineralization, and mechanical properties of C. carpio rib bone. J Biomed Mater Res 54:547-53. Sheehy JW, Jones JH (1993) Assessment of arsenic exposures and controls in gallium arsenide production. Am Ind Hyg Assoc J 54 :61-9. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB, Newman AB (2004) Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res 19:1084-91. Tang CH, Yang RS, Chien MY, Chen CC, Fu WM (2008) Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Eur J Pharmacol 579 :40-9. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504-8. Ter Brugge PJ, Jansen JA (2002) Initial interaction of rat bone marrow cells with non-coated and calcium phosphate coated titanium substrates. Biomaterials 23:3269-77. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst 40: 453-463. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ (2002) Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55:693-8. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 18:427-44. Wang L, Wu Z, Yan J, Yang H, Chen Z (2006) Culture and differentiation of human orbital preadipocytes in thyroid-associated ophthalmopathy. Yan Ke Xue Bao 21(1):27-30, 37. Wang ZX, Jiang CS, Liu L, Wang XH, Jin HJ, Wu Q, Chen Q (2005) The role of Akt on arsenic trioxide suppression of 3T3-L1 preadipocyte differentiation. Cell Res 15 :379-86. Wakitani S, Saito T, Caplan AI (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-26. Wen WN, Lieu TL, Chang HJ, Wuu SW, Yau ML, Jan KY (1981) Baseline and sodium arsenite-induced sister chromatid exchanges in cultured lymphocytes from patients with Blackfoot disease and healthy persons. Hum Genet 59:201-3. Yang X, Karsenty G (2002) Transcription factors in bone: developmental and pathological aspects. Trends Mol Med 8:340-5. Zhang LL, Yan Liu D, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, Schrader M, Thilo F, Zhu ZM, Tepel M (2007) Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 100:1063-70. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41475 | - |
| dc.description.abstract | 骨質疏鬆症一般被認為是細胞的骨生成作用與破骨細胞的骨吸收作用失去平衡，然而近年來的研究指出骨頭內的間質幹細胞分化成造骨細胞的能力減弱或是間質幹細胞分化成脂肪細胞的能力增強，這樣的結果往往會導致骨質疏鬆症，如糖尿病狀態。 砷為環境中普遍存在的毒性危害物質，我們的水源、空氣包括生物體內都有存在砷，因此人們很容易暴露到砷，砷主要經呼吸、皮膚及消化道吸收，進而 分佈於我們的組織和器官而造成傷害，如皮膚和骨頭，但過去的研究鮮少去探討砷會於骨生成的影響。 因此，本篇主是探討砷化物中的三氧化二砷對於間質幹細胞分化成造骨細胞和脂肪細胞的影響。首先我們選定了不造成細胞死亡的劑量：0.5 μM和1 μM，在此劑量下我們發現三氧化二砷會透過抑制AMPK、eNOS、BMP-2、ALP和OCN的表現來達到抑制骨生成，三氧化二砷對於脂肪細胞分化方面，0.5 μM及1 μM三氧化二砷有促進脂肪細胞分化的現象，而我們也發現在此劑量下三氧化二砷會透過ERK的磷酸化促進脂肪細胞的分化和抑制骨礦物化。在動物實驗上，我們將1 μM三氧化二砷在大鼠脛骨作局部注射和以0.5 ppm和5 ppm三氧化二砷水溶液對鼷鼠連續餵食六週，發現經三氧化二砷處理後，經細胞分化測試、骨密度測定和骨組織切片看到實驗動物的骨生成受到抑制。
綜合以上實驗結果，我們認為三氧化二砷0.5及1 μM劑量下有助於MSCs趨向分化成脂肪細胞同時也抑制了骨生成。 | zh_TW |
| dc.description.abstract | In general, osteoporosis is a disease of bone which is caused by an imbalance between osteoblastic bone formation and osteoclastic bone resorption. However, the recent research showed that the ability of bone marrow mesenchymal stem cells differentiates into adipocytes is greater than osteoblasts and it was thought to cause into osteoporosis, such as diabetes. Arsenic is a common environmental toxicant including in water and air, and we expose to arsenic easily. Arsenic is mainly absorbed via breathing, skin and digestive tract, and then it distributes into our tissues and organs, such as skin and bone. However, few studies show the effects of arsenic to bone. Here we used arsenic trioxide to understand how it affects osteogenesis and adipogenesis of bone marrow mesenchymal stem cells. At first, we selected the arsenic trioxide dose(0.5 μM and 1 μM) that do not cause MSCs death. After 0.5 μM and 1 μM arsenic trioxide treatment, we found that arsenic trioxide inhibited bone formation via decreasing the expressions of AMPK、eNOS、BMP-2、ALP and OCN. Moreover, we also found that 0.5 μM and 1 μM arsenic trioxide can increase adipocyte differentiation and depressed bone formation via the phosphorylation of ERK. In animal test, we injected 1 μM arsenic trioxide into the tibia of rats and fed 0.5 and 5 ppm arsenic trioxide to mice for 6 weeks. The data of BMD, cell differentiation, and slices show the ability of bone formation in animal was inhibited. In Conclusion, we thought that 0.5 μM and 1 μM arsenic trioxide help MSCs favor adipogenesis and it also inhibited osteogenesis. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T00:20:15Z (GMT). No. of bitstreams: 1 ntu-98-R95447005-1.pdf: 1495786 bytes, checksum: 0a67da4757afd46b120de9bc2894d99f (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 目錄....................................3
中文摘要............................4 英文摘要............................6 縮寫表.................................8 第一章 緒論.....................10 第二章 材料與方法.........20 第三章 結果......................30 第四章 討論.......................36 附圖.......................................42 參考文獻...............................64 | |
| dc.language.iso | zh-TW | |
| dc.subject | 骨質酥鬆症 | zh_TW |
| dc.subject | 造骨細胞分化 | zh_TW |
| dc.subject | 間質幹細胞 | zh_TW |
| dc.subject | 脂肪細胞分化 | zh_TW |
| dc.subject | 三氧化二砷 | zh_TW |
| dc.subject | osteogenesis | en |
| dc.subject | mesenchymal stem cells | en |
| dc.subject | adipogenesis | en |
| dc.subject | osteoporosis and arsenic trioxide | en |
| dc.title | 三氧化二砷對於骨髓間質幹細胞分化成造骨
細胞和脂肪細胞的影響 | zh_TW |
| dc.title | Effects of Arsenic Trioxide on Osteogenesis and Adipogenesis from Bone Marrow Mesenchymal Stem Cells | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 楊榮森(Rong-Sen Yang),蕭水銀(Shoei-Yn Lin-Shiau) | |
| dc.subject.keyword | 間質幹細胞,造骨細胞分化,脂肪細胞分化,骨質酥鬆症,三氧化二砷, | zh_TW |
| dc.subject.keyword | mesenchymal stem cells,adipogenesis,osteogenesis,osteoporosis and arsenic trioxide, | en |
| dc.relation.page | 70 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-02-10 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 毒理學研究所 | zh_TW |
| 顯示於系所單位： | 毒理學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 1.46 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。